Clinical Trial Update: Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy [NA]

View source ↗

Summary

A clinical trial evaluating Rituximab, Cyclophosphamide, and Corticosteroids for PLA2R-induced membranous nephropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Corticosteroids (corticosteroids)
• Rituximab (rituximab)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Membranous Nephropathy - PLA2R Induced | NA | Status: RECRUITING